Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Neurobiol Dis ; 73: 275-88, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25315682

ABSTRACT

miR-29 is expressed strongly in the brain and alterations in expression have been linked to several neurological disorders. To further explore the function of this miRNA in the brain, we generated miR-29a/b-1 knockout animals. Knockout mice develop a progressive disorder characterized by locomotor impairment and ataxia. The different members of the miR-29 family are strongly expressed in neurons of the olfactory bulb, the hippocampus and in the Purkinje cells of the cerebellum. Morphological analysis showed that Purkinje cells are smaller and display less dendritic arborisation compared to their wildtype littermates. In addition, a decreased number of parallel fibers form synapses on the Purkinje cells. We identified several mRNAs significantly up-regulated in the absence of the miR-29a/b-1 cluster. At the protein level, however, the voltage-gated potassium channel Kcnc3 (Kv3.3) was significantly up-regulated in the cerebella of the miR-29a/b knockout mice. Dysregulation of KCNC3 expression may contribute to the ataxic phenotype.


Subject(s)
Ataxia/metabolism , Cerebellum/metabolism , MicroRNAs/metabolism , Purkinje Cells/metabolism , Shaw Potassium Channels/metabolism , Animals , Behavior, Animal , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity
2.
EMBO Mol Med ; 5(10): 1613-34, 2013 10.
Article in English | MEDLINE | ID: mdl-24014289

ABSTRACT

An overview of miRNAs altered in Alzheimer's disease (AD) was established by profiling the hippocampus of a cohort of 41 late-onset AD (LOAD) patients and 23 controls, showing deregulation of 35 miRNAs. Profiling of miRNAs in the prefrontal cortex of a second independent cohort of 49 patients grouped by Braak stages revealed 41 deregulated miRNAs. We focused on miR-132-3p which is strongly altered in both brain areas. Downregulation of this miRNA occurs already at Braak stages III and IV, before loss of neuron-specific miRNAs. Next-generation sequencing confirmed a strong decrease of miR-132-3p and of three family-related miRNAs encoded by the same miRNA cluster on chromosome 17. Deregulation of miR-132-3p in AD brain appears to occur mainly in neurons displaying Tau hyper-phosphorylation. We provide evidence that miR-132-3p may contribute to disease progression through aberrant regulation of mRNA targets in the Tau network. The transcription factor (TF) FOXO1a appears to be a key target of miR-132-3p in this pathway.


Subject(s)
Alzheimer Disease/genetics , MicroRNAs/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Area Under Curve , Brain/metabolism , Chromosomes, Human, Pair 17 , Cluster Analysis , Cohort Studies , Disease Progression , Down-Regulation , Gene Expression Profiling , High-Throughput Nucleotide Sequencing , Hippocampus/metabolism , Humans , Neurons/metabolism , Phosphorylation , ROC Curve , Severity of Illness Index , tau Proteins/metabolism
3.
Breast Cancer Res ; 15(2): R29, 2013 Apr 08.
Article in English | MEDLINE | ID: mdl-23566419

ABSTRACT

INTRODUCTION: Cyclooxygenase-2 (COX-2) is frequently over-expressed in primary breast cancer. In transgenic breast cancer models, over-expression of COX-2 leads to tumour formation while COX-2 inhibition exerts anti-tumour effects in breast cancer cell lines. To further determine the effect of COX-2 inhibition in primary breast cancer, we aimed to identify transcriptional changes in breast cancer tissues of patients treated with the selective COX-2 inhibitor celecoxib. METHODS: In a single-centre double-blind phase II study, thirty-seven breast cancer patients were randomised to receive either pre-operative celecoxib (400 mg) twice daily for two to three weeks (n = 22) or a placebo according to the same schedule (n = 15). Gene expression in fresh-frozen pre-surgical biopsies (before treatment) and surgical excision specimens (after treatment) was profiled by using Affymetrix arrays. Differentially expressed genes and altered pathways were bioinformatically identified. Expression of selected genes was validated by quantitative PCR (qPCR). Immunohistochemical protein expression analyses of the proliferation marker Ki-67, the apoptosis marker cleaved caspase-3 and the neo-angiogenesis marker CD34 served to evaluate biological response. RESULTS: We identified 972 and 586 significantly up- and down-regulated genes, respectively, in celecoxib-treated specimens. Significant expression changes in six out of eight genes could be validated by qPCR. Pathway analyses revealed over-representation of deregulated genes in the networks of proliferation, cell cycle, extracellular matrix biology, and inflammatory immune response. The Ki-67 mean change relative to baseline was -29.1% (P = 0.019) and -8.2% (P = 0.384) in the treatment and control arm, respectively. Between treatment groups, the change in Ki-67 was statistically significant (P = 0.029). Cleaved caspase-3 and CD34 expression were not significantly different between the celecoxib-treated and placebo-treated groups. CONCLUSIONS: Short-term COX-2 inhibition by celecoxib induces transcriptional programs supporting anti-tumour activity in primary breast cancer tissue. The impact on proliferation-associated genes is reflected by a reduction of Ki-67 positive cells. Therefore, COX-2 inhibition should be considered as a treatment strategy for further clinical testing in primary breast cancer. TRIAL REGISTRATION: ClinicalTrials.gov NCT01695226.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Cyclooxygenase Inhibitors/therapeutic use , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Pyrazoles/therapeutic use , Sulfonamides/therapeutic use , Biomarkers, Tumor , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/drug therapy , Carcinoma, Ductal, Breast/genetics , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/drug therapy , Carcinoma, Lobular/genetics , Carcinoma, Lobular/pathology , Celecoxib , Double-Blind Method , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Grading , Oligonucleotide Array Sequence Analysis , Prognosis , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
4.
Biochem Biophys Res Commun ; 402(2): 203-8, 2010 Nov 12.
Article in English | MEDLINE | ID: mdl-20888800

ABSTRACT

Despite the mitochondria ubiquitous nature many of their components display divergences in their expression profile across different tissues. Using the bioinformatics-approach of guilt by association (GBA) we exploited these variations to predict the function of two so far poorly annotated genes: Coiled-coil-helix-coiled-coil-helix domain containing 10 (CHCHD10) and glioblastoma amplified sequence (GBAS). We predicted both genes to be involved in oxidative phosphorylation. Through in vitro experiments using gene-knockdown we could indeed confirm this and furthermore we asserted CHCHD10 to play a role in complex IV activity.


Subject(s)
Adenosine Triphosphate/biosynthesis , Electron Transport Complex IV/metabolism , Genes, Mitochondrial/physiology , Heart/physiology , Membrane Proteins/physiology , Mitochondrial Proteins/physiology , Oxidative Phosphorylation , Phosphoproteins/physiology , Computational Biology/methods , Gene Knockdown Techniques , HeLa Cells , Humans , Intracellular Signaling Peptides and Proteins , Membrane Proteins/genetics , Mitochondrial Proteins/genetics , Phosphoproteins/genetics
5.
Physiol Genomics ; 42A(4): 283-9, 2010 Nov 29.
Article in English | MEDLINE | ID: mdl-20858713

ABSTRACT

Cardiomyocytes in vivo are continuously subjected to electrical signals that evoke contractions and instigate drastic changes in the cells' morphology and function. Studies on how electrical stimulation affects the cardiac transcriptome have remained limited to a small number of heart-specific genes. Furthermore, these studies have ignored the interplay between the electrical excitation and the subsequent contractions. We carried out a genomewide assessment of the effects of electrical signaling on gene expression, while distinguishing between the effects deriving from the electrical pulses themselves and the effects instigated by the evoked contractions. Changes in gene expression in primary cultures of neonatal ventricular cardiomyocytes from Lewis Rattus norvegicus were investigated with microarrays and RT-quantitative PCR (QPCR). A series of experiments was included in which the culture medium was supplemented with the contraction inhibitor blebbistatin to allow for electrical stimulation in the absence of contraction. Electrical stimulation was shown to directly enhance calcium handling and induce cardiomyocyte differentiation by arresting cell division and activating key cardiac transcription factors as well as additional differentiation mechanisms such as wnt signaling. Several genes involved in metabolism were also directly activated by electrical stimulation. Furthermore, our data suggest that contraction exerts negative feedback on the transcription of various genes. Together, these observations indicate that intercellular electric currents between adjacent cardiomyocytes have an important role in cardiomyocyte development. They act at least partially through a pulse-specific gene expression program that is activated independently from the evoked contractions.


Subject(s)
Gene Expression Profiling , Myocytes, Cardiac/physiology , Animals , Cell Separation , Electric Stimulation , Female , Heterocyclic Compounds, 4 or More Rings , Male , Myocardial Contraction/drug effects , Rats
6.
Biotechniques ; 48(1): 65-7, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20078430

ABSTRACT

The study of gene regulation in cardiac myocytes requires a reliable in vitro model. However, monolayer cultures used for this purpose are typically not exposed to electrical stimulation, though this has been shown to strongly affect cardiomyocyte gene expression. Based on pacemakers for clinical use, we developed an easy-to-use portable system that allows the user to perform electro-stimulation of cardiomyocyte cultures in standard tissue incubators without the need for bulky equipment. In addition, we present a refined protocol for culturing high-purity cardiomyocyte cultures with excellent contractile properties for a wide variety of applications.


Subject(s)
Cell Culture Techniques/instrumentation , Electric Stimulation/instrumentation , Myocytes, Cardiac/cytology , Pacemaker, Artificial , Animals , Cell Culture Techniques/methods , Cells, Cultured , Electric Stimulation/methods , Equipment Design , Gene Expression Regulation , Myocytes, Cardiac/metabolism , Rats , Rats, Inbred Lew
7.
Arterioscler Thromb Vasc Biol ; 29(9): 1322-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19667116

ABSTRACT

OBJECTIVE: Activating transcription factor 6 (ATF6) is a sensor of the endoplasmic reticulum stress response and regulates expression of several key lipogenic genes. We used a 2-stage design to investigate whether ATF6 polymorphisms are associated with lipids in subjects at increased risk for cardiovascular disease (CVD). METHODS AND RESULTS: In stage 1, 13 tag-SNPs were tested for association in Dutch samples ascertained for familial combined hyperlipidemia (FCHL) or increased risk for CVD (CVR). In stage 2, we further investigated the SNP with the strongest association from stage 1, a Methionine/Valine substitution at amino-acid 67, in Finnish FCHL families and in subjects with CVR from METSIM, a Finnish population-based cohort. The combined analysis of both stages reached region-wide significance (P=9 x 10(-4)), but this association was not seen in the entire METSIM cohort. Our functional analysis demonstrated that Valine at position 67 augments ATF6 protein and its targets Grp78 and Grp94 as well as increases luciferase expression through Grp78 promoter. CONCLUSIONS: A common nonsynonymous variant in ATF6 increases ATF6 protein levels and is associated with cholesterol levels in subjects at increased risk for CVD, but this association was not seen in a population-based cohort. Further replication is needed to confirm the role of this variant in lipids.


Subject(s)
Activating Transcription Factor 6/genetics , Cardiovascular Diseases/genetics , Cholesterol/blood , Hyperlipidemia, Familial Combined/genetics , Polymorphism, Single Nucleotide , Activating Transcription Factor 6/blood , Amino Acid Substitution , Apolipoproteins B/blood , Cardiovascular Diseases/blood , Cohort Studies , Endoplasmic Reticulum Chaperone BiP , Finland , Genetic Predisposition to Disease , HeLa Cells , Heat-Shock Proteins/genetics , Heat-Shock Proteins/metabolism , Humans , Hyperlipidemia, Familial Combined/blood , Membrane Glycoproteins/metabolism , Methionine , Netherlands , Promoter Regions, Genetic , Risk Assessment , Transfection , Up-Regulation , Valine
8.
Physiol Genomics ; 36(1): 15-23, 2008 Dec 12.
Article in English | MEDLINE | ID: mdl-18812456

ABSTRACT

Peroxisome proliferator-activated receptor (PPAR)alpha regulates lipid metabolism at the transcriptional level and modulates the expression of genes involved in inflammation, cell proliferation, and differentiation. Although PPARalpha has been shown to mitigate cardiac hypertrophy, knowledge about underlying mechanisms and the nature of signaling pathways involved is fragmentary and incomplete. The aim of this study was to identify the processes and signaling pathways regulated by PPARalpha in hearts challenged by a chronic pressure overload by means of whole genome transcriptomic analysis. PPARalpha-/- and wild-type mice were subjected to transverse aortic constriction (TAC) for 28 days, and left ventricular gene expression profile was determined with Affymetrix GeneChip Mouse Genome 430 2.0 arrays containing >45,000 probe sets. In unchallenged hearts, the mere lack of PPARalpha resulted in 821 differentially expressed genes, many of which are related to lipid metabolism and immune response. TAC resulted in a more pronounced cardiac hypertrophy and more extensive changes in gene expression (1,910 and 312 differentially expressed genes, respectively) in PPARalpha-/- mice than in wild-type mice. Many of the hypertrophy-related genes were related to development, signal transduction, actin filament organization, and collagen synthesis. Compared with wild-type hypertrophied hearts, PPARalpha-/- hypertrophied hearts revealed enrichment of gene clusters related to extracellular matrix remodeling, immune response, oxidative stress, and inflammatory signaling pathways. The present study therefore demonstrates that, in addition to lipid metabolism, PPARalpha is an important modulator of immune and inflammatory response in cardiac muscle.


Subject(s)
Cardiomegaly/genetics , Gene Expression Profiling , PPAR alpha/metabolism , Animals , Cardiomegaly/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myocardium/metabolism , PPAR alpha/genetics , Signal Transduction , Transcription, Genetic
9.
Mol Hum Reprod ; 14(3): 157-68, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18204071

ABSTRACT

Besides the established selection criteria based on embryo morphology and blastomere number, new parameters for embryo viability are needed to improve the clinical outcome of IVF and more particular of elective single-embryo transfer. Genome-wide gene expression in cumulus cells was studied, since these cells surround the oocyte inside the follicle and therefore possibly reflect oocyte developmental potential. Early cleavage (EC) was chosen as a parameter for embryo viability. Gene expression in cumulus cells from eight oocytes resulting in an EC embryo (EC-CC; n = 8) and from eight oocytes resulting in a non-EC (NEC) embryo (NEC-CC; n = 8) was analysed using microarrays (n = 16). A total of 611 genes were differentially expressed (P < 0.01), mainly involved in cell cycle, angiogenesis, apoptosis, epidermal growth factor, fibroblast growth factor and platelet-derived growth factor signalling, general vesicle transport and chemokine and cytokine signalling. Of the 25 selected differentially expressed genes analysed by quantitative real-time PCR 15 (60%) genes could be validated in the original samples. Of these 8 (53%) could also be validated in 24 (12-EC-CC and 12 NEC-CC) extra independent samples. The most differentially expressed genes among these were CCND2, CXCR4, GPX3, CTNND1 DHCR7, DVL3, HSPB1 and TRIM28, which probably point to hypoxic conditions or a delayed oocyte maturation in NEC-CC samples. This opens up perspectives for new molecular embryo or oocyte selection parameters which might also be useful in countries where the selection has to be made at the oocyte stage before fertilization instead of at the embryonic stage.


Subject(s)
Cumulus Cells/metabolism , Embryo, Mammalian/metabolism , Gene Expression Profiling , Cell Survival/genetics , Cells, Cultured , Cumulus Cells/cytology , Embryo, Mammalian/cytology , Female , Humans , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction
10.
J Clin Endocrinol Metab ; 92(7): 2720-5, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17440018

ABSTRACT

CONTEXT: Activating transcription factor 6 (ATF6) is critical for initiation and full activation of the unfolded protein response. An association between genetic variation in ATF6 and type 2 diabetes (DM2) was recently reported in Pima Indians. OBJECTIVES: To investigate the broader significance of this association for DM2, replication studies in distinct ethic populations are required. We investigated ATF6 for its association with DM2 in Dutch Caucasians. DESIGN/SETTING: A genetic association study was conducted at an academic research laboratory. STUDY PARTICIPANTS: Two independent Dutch cohorts were studied. Cohort 1 (n = 154) was used to evaluate genetic variation in the ATF6 gene in relation to glucose homeostasis in the general population. Cohort 2 (n = 798) consisted of patients with DM2, impaired glucose tolerance, impaired fasting glucose, and normoglycemic control subjects, and was used to investigate ATF6 polymorphisms for their contribution to disturbed glucose homeostasis and DM2. MAIN OUTCOME MEASURES: There were 16 tag single nucleotide polymorphisms genotyped in all subjects of both cohorts. Those single nucleotide polymorphisms included three nonsynonymous coding variants and captured all common allelic variation of ATF6. RESULTS: Our data show that common ATF6 variants are associated with elevated glucose levels in the general population (cohort 1, P = 0.005-0.05). Furthermore, the majority of these variants, and haplotypes thereof, were significantly associated with impaired fasting glucose, impaired glucose tolerance, and DM2 (cohort 2, P = 0.006-0.05). Associated variants differ from those identified in Pima Indians. CONCLUSIONS: Our results strengthen the evidence that one or more variants in ATF6 are associated with disturbed glucose homeostasis and DM2.


Subject(s)
Activating Transcription Factor 6/genetics , Diabetes Mellitus, Type 2/ethnology , Diabetes Mellitus, Type 2/genetics , Glucose Intolerance/ethnology , Glucose Intolerance/genetics , Aged , Blood Glucose , Diabetes Mellitus, Type 2/metabolism , Fasting , Female , Gene Frequency , Genetic Predisposition to Disease , Glucose Intolerance/metabolism , Haplotypes , Homeostasis/genetics , Humans , Male , Middle Aged , Netherlands/epidemiology , Polymorphism, Genetic , White People/genetics , White People/statistics & numerical data
11.
BMC Cell Biol ; 6(1): 1, 2005 Jan 13.
Article in English | MEDLINE | ID: mdl-15649318

ABSTRACT

BACKGROUND: At sites of cell adhesion, proteins exist that not only perform structural tasks but also have a signaling function. Previously, we found that the Lipoma Preferred Partner (LPP) protein is localized at sites of cell adhesion such as focal adhesions and cell-cell contacts, and shuttles to the nucleus where it has transcriptional activation capacity. LPP is a member of the zyxin family of proteins, which contains five members: ajuba, LIMD1, LPP, TRIP6 and zyxin. LPP has three LIM domains (zinc-finger protein interaction domains) at its carboxy-terminus, which are preceded by a proline-rich pre-LIM region containing a number of protein interaction domains. RESULTS: To catch the role of LPP at sites of cell adhesion, we made an effort to identify binding partners of LPP. We found the tumor suppressor protein Scrib, which is a component of cell-cell contacts, as interaction partner of LPP. Human Scrib, which is a functional homologue of Drosophila scribble, is a member of the leucine-rich repeat and PDZ (LAP) family of proteins that is involved in the regulation of cell adhesion, cell shape and polarity. In addition, Scrib displays tumor suppressor activity. The binding between Scrib and LPP is mediated by the PDZ domains of Scrib and the carboxy-terminus of LPP. Both proteins localize in cell-cell contacts. Whereas LPP is also localized in focal adhesions and in the nucleus, Scrib could not be detected at these locations in MDCKII and CV-1 cells. Furthermore, our investigations indicate that Scrib is dispensable for targeting LPP to focal adhesions and to cell-cell contacts, and that LPP is not necessary for localizing Scrib in cell-cell contacts. We show that all four PDZ domains of Scrib are dispensable for localizing this protein in cell-cell contacts. CONCLUSIONS: Here, we identified an interaction between one of zyxin's family members, LPP, and the tumor suppressor protein Scrib. Both proteins localize in cell-cell contacts. This interaction links Scrib to a communication pathway between cell-cell contacts and the nucleus, and implicates LPP in Scrib-associated functions.


Subject(s)
Active Transport, Cell Nucleus , Cell Adhesion , Cytoskeletal Proteins/metabolism , Membrane Proteins/metabolism , Tumor Suppressor Proteins/metabolism , Binding Sites , Cell Line , Humans , LIM Domain Proteins , Membrane Proteins/genetics , Protein Binding , Protein Structure, Tertiary , Protein Transport , Transfection , Tumor Suppressor Proteins/genetics
12.
FEBS Lett ; 569(1-3): 277-83, 2004 Jul 02.
Article in English | MEDLINE | ID: mdl-15225648

ABSTRACT

The developmentally regulated architectural transcription factor, high mobility group A2 (HMGA2), is involved in growth regulation and plays an important role in embryogenesis and tumorigenesis. Little is known, however, about its downstream targets. We performed a search for genes of which expression is strongly altered during embryonic development in two HMGA2-deficient mouse strains, which display a pygmy-phenotype, as compared to wild-type mice. We found that the insulin-like growth factor II mRNA-binding protein 2 gene (IMP2), but not its family members IMP1 and IMP3, was robustly downregulated in mutant E12.5 embryos. Furthermore, we show that wild-type HMGA2 and its tumor-specific truncated form have opposite effects on IMP2 expression. Our results clearly indicate that HMGA2 differentially regulates expression of IMP family members during embryogenesis.


Subject(s)
Gene Expression Regulation/genetics , HMGA2 Protein/metabolism , Insulin-Like Growth Factor II/genetics , RNA, Messenger/genetics , RNA-Binding Proteins/metabolism , Transcription, Genetic/genetics , Amino Acid Sequence , Animals , Base Sequence , Conserved Sequence , DNA Primers , Embryonic and Fetal Development , HMGA2 Protein/deficiency , HMGA2 Protein/genetics , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Neoplasm Proteins , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Plasmids , Recombinant Proteins/metabolism , Sequence Alignment , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...